Table 1.
UC-1 | UC-2 | |||
---|---|---|---|---|
Disc (mg) | BCNU (mg) | Disc (mg) | BCNU (mg) | |
Trial 1 (Day 0) |
8.29 | 0.67 (8%) | 7.88 | 0.41 (5.2%) |
Trial 2 (Day 5) |
10.12 | 0.80 (7.9%) | 8.56 | 0.44 (5.1%) |
Trial 3 (Day 5) |
9.93 | 0.77 (7.8%) | N/A | N/A |
UC-1 | UC-2 | |||
---|---|---|---|---|
Disc (mg) | BCNU (mg) | Disc (mg) | BCNU (mg) | |
Trial 1 (Day 0) |
8.29 | 0.67 (8%) | 7.88 | 0.41 (5.2%) |
Trial 2 (Day 5) |
10.12 | 0.80 (7.9%) | 8.56 | 0.44 (5.1%) |
Trial 3 (Day 5) |
9.93 | 0.77 (7.8%) | N/A | N/A |